SE0001865D0 - Management of septic shock - Google Patents
Management of septic shockInfo
- Publication number
- SE0001865D0 SE0001865D0 SE0001865A SE0001865A SE0001865D0 SE 0001865 D0 SE0001865 D0 SE 0001865D0 SE 0001865 A SE0001865 A SE 0001865A SE 0001865 A SE0001865 A SE 0001865A SE 0001865 D0 SE0001865 D0 SE 0001865D0
- Authority
- SE
- Sweden
- Prior art keywords
- septic shock
- pharmaceutical composition
- management
- sterile pharmaceutical
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0001865A SE0001865D0 (sv) | 2000-05-19 | 2000-05-19 | Management of septic shock |
| US09/849,591 US20020037933A1 (en) | 2000-05-19 | 2001-05-07 | Management of septic shock |
| JP2001583757A JP2003533476A (ja) | 2000-05-19 | 2001-05-15 | 敗血症ショックの治療 |
| KR1020027015536A KR20020097482A (ko) | 2000-05-19 | 2001-05-15 | 패혈증 치료용 프로포폴 |
| BR0110982-0A BR0110982A (pt) | 2000-05-19 | 2001-05-15 | Composição farmacêutica estéril para administração parenteral, uso do composto 2,6-diisopropil-fenol (propofol), uso de uma composição farmacêutica estéril para administração parenteral, método de manejo do choque séptico, e, método de contraposição à deterioração induzida por endotoxina da tensão de oxigênio arterial |
| CN01809726A CN1430509A (zh) | 2000-05-19 | 2001-05-15 | 控制败血症性休克 |
| PCT/GB2001/002117 WO2001087289A2 (fr) | 2000-05-19 | 2001-05-15 | Gestion de choc septique |
| AU2001254990A AU2001254990A1 (en) | 2000-05-19 | 2001-05-15 | Propofol for treatment of sepsis |
| EP01928126A EP1296664A2 (fr) | 2000-05-19 | 2001-05-15 | Gestion de choc septique |
| IL15247101A IL152471A0 (en) | 2000-05-19 | 2001-05-15 | Propofol for treatment of sepsis |
| CA002407540A CA2407540A1 (fr) | 2000-05-19 | 2001-05-15 | Gestion de choc septique |
| MXPA02011240A MXPA02011240A (es) | 2000-05-19 | 2001-05-15 | Manejo de choque septico. |
| ZA200208893A ZA200208893B (en) | 2000-05-19 | 2002-11-01 | Propofol for treatment of sepsis. |
| NO20025530A NO20025530L (no) | 2000-05-19 | 2002-11-18 | Håndtering av septisk sjokk |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0001865A SE0001865D0 (sv) | 2000-05-19 | 2000-05-19 | Management of septic shock |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0001865D0 true SE0001865D0 (sv) | 2000-05-19 |
Family
ID=20279747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0001865A SE0001865D0 (sv) | 2000-05-19 | 2000-05-19 | Management of septic shock |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20020037933A1 (fr) |
| EP (1) | EP1296664A2 (fr) |
| JP (1) | JP2003533476A (fr) |
| KR (1) | KR20020097482A (fr) |
| CN (1) | CN1430509A (fr) |
| AU (1) | AU2001254990A1 (fr) |
| BR (1) | BR0110982A (fr) |
| CA (1) | CA2407540A1 (fr) |
| IL (1) | IL152471A0 (fr) |
| MX (1) | MXPA02011240A (fr) |
| NO (1) | NO20025530L (fr) |
| SE (1) | SE0001865D0 (fr) |
| WO (1) | WO2001087289A2 (fr) |
| ZA (1) | ZA200208893B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU759641B2 (en) * | 1998-08-19 | 2003-04-17 | Skyepharma Canada Inc. | Injectable aqueous dispersions of propofol |
| KR20070087004A (ko) * | 2002-04-08 | 2007-08-27 | 엠쥐아이 쥐피, 아이엔씨. | 프로포폴의 수용성 프로드럭을 함유하는 약제학적 조성물및 그것을 투여하는 방법 |
| WO2003105817A1 (fr) * | 2002-05-02 | 2003-12-24 | Fdl, Inc. | Nouvelle composition parenterale a base de propofol |
| AU2006310113A1 (en) * | 2005-08-05 | 2007-05-10 | Bharat Serums & Vaccines Ltd. | Intravenous propofol emulsion compositions having preservative efficacy |
| US7727730B2 (en) * | 2005-12-09 | 2010-06-01 | Corgenix Medical Corporation | Methods and kits for detection of thromboxane A2 metabolites |
| WO2011161687A1 (fr) * | 2010-06-23 | 2011-12-29 | Harman Finochem Limited | Procédé pour la préparation de 2,6-diisopropylphénol extra pur |
| CN102525921B (zh) * | 2012-02-06 | 2013-08-07 | 西安力邦制药有限公司 | 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法 |
| CN109470762B (zh) * | 2017-09-07 | 2020-12-29 | 中国科学院大连化学物理研究所 | 一种准确识别丙泊酚注射液是否过期的方法 |
| US20220008499A1 (en) * | 2018-11-15 | 2022-01-13 | Ferring B.V. | Compounds, compositions and methods for treating sepsis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
-
2000
- 2000-05-19 SE SE0001865A patent/SE0001865D0/xx unknown
-
2001
- 2001-05-07 US US09/849,591 patent/US20020037933A1/en not_active Abandoned
- 2001-05-15 CN CN01809726A patent/CN1430509A/zh active Pending
- 2001-05-15 WO PCT/GB2001/002117 patent/WO2001087289A2/fr not_active Ceased
- 2001-05-15 MX MXPA02011240A patent/MXPA02011240A/es unknown
- 2001-05-15 AU AU2001254990A patent/AU2001254990A1/en not_active Abandoned
- 2001-05-15 KR KR1020027015536A patent/KR20020097482A/ko not_active Withdrawn
- 2001-05-15 IL IL15247101A patent/IL152471A0/xx unknown
- 2001-05-15 CA CA002407540A patent/CA2407540A1/fr not_active Abandoned
- 2001-05-15 BR BR0110982-0A patent/BR0110982A/pt not_active Application Discontinuation
- 2001-05-15 JP JP2001583757A patent/JP2003533476A/ja active Pending
- 2001-05-15 EP EP01928126A patent/EP1296664A2/fr not_active Withdrawn
-
2002
- 2002-11-01 ZA ZA200208893A patent/ZA200208893B/en unknown
- 2002-11-18 NO NO20025530A patent/NO20025530L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02011240A (es) | 2003-03-10 |
| IL152471A0 (en) | 2003-05-29 |
| JP2003533476A (ja) | 2003-11-11 |
| CA2407540A1 (fr) | 2001-11-22 |
| US20020037933A1 (en) | 2002-03-28 |
| ZA200208893B (en) | 2004-02-19 |
| NO20025530L (no) | 2003-01-14 |
| WO2001087289A2 (fr) | 2001-11-22 |
| KR20020097482A (ko) | 2002-12-31 |
| NO20025530D0 (no) | 2002-11-18 |
| WO2001087289A3 (fr) | 2002-05-16 |
| CN1430509A (zh) | 2003-07-16 |
| BR0110982A (pt) | 2003-04-08 |
| AU2001254990A1 (en) | 2001-11-26 |
| EP1296664A2 (fr) | 2003-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9907832A (pt) | Composição de propofol contendo sulfito | |
| BR9913221A (pt) | Composições catalisadoras sustentadas altamente ativas | |
| BR0317822A (pt) | Composição fluoroquìmica | |
| BR0010242A (pt) | Composições quìmicas que atraem artrópodes | |
| IS2750B (is) | Leiðarafesting | |
| SE0301888D0 (sv) | New use VII | |
| PA8486001A1 (es) | Composiciones de celecoxib | |
| UY26092A1 (es) | Uso de inhibidores de cyp2d6 en terapias de combinacion | |
| SE0301886D0 (sv) | New use V | |
| PA8548001A1 (es) | Derivados aromaticos de acidos dicarboxilicos | |
| ID28263A (id) | DIPEPTIDA OKSAMIL TERMODIFIKASI C-TERMINAL SEBAGAI PENGHAMBAT PADA KELUARGA ICE-ced-3 DARI PROTEASE SISTEINA | |
| SE0301882D0 (sv) | New use I | |
| DE60236117D1 (de) | Phosphattransporthemmer | |
| TNSN06359A1 (fr) | Aryl-ou heteroaryl-amides substitues en position ortho | |
| SE0001865D0 (sv) | Management of septic shock | |
| UA89315C2 (en) | Butylbenzene phthalein intravenous emulsion | |
| KR960700217A (ko) | 액체 페놀성 산화방지제 | |
| BR0000544A (pt) | Poliolefinas de metaloceno estabilizadas | |
| ATE468381T1 (de) | Neuer kraftstoff mit hoher oktanzahl und geringem aromatengehalt | |
| ATE538124T1 (de) | Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit | |
| ATE516031T1 (de) | Verbindungen gegen krebs | |
| AR043253A1 (es) | 4-[(2,4-dicloro-5-metoxifenil)amino] -6- alcoxi-3-quinolina carbonitrilos para el tratamiento de lesiones isquemicas | |
| ECSP066548A (es) | 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica | |
| BR9508342A (pt) | Compostos orgânicos | |
| CO5280199A1 (es) | Composicion |